TickerFacts.

Beta Bionics, Inc. (BBNX): Gross Profit

Annual figures by period end, from SEC filings.

$55.54M
Year ended 2025-12-31
$69.40M
Trailing 12 months to 2026-06-30
2023-12-31: $6.31M2024-12-31: $35.89M2025-12-31: $55.54M$55.54M
2023-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$55.54M+54.8%2026-02-24, From 2025-01-01
2024-12-31$35.89M+468.9%2026-02-24, From 2024-01-01
2023-12-31$6.31Mn/a2025-03-28, From 2023-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Beta Bionics, Inc. (BBNX)2025-12-31$55.54M+54.8%
NeuroPace Inc (NPCE)2025-12-31$77.22M+30.7%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$48.86M+101.8%
Pulmonx Corp (LUNG)2025-12-31$67.14M+8.3%
Anika Therapeutics, Inc. (ANIK)2025-12-31$63.81M-16.0%
Orasure Technologies Inc (OSUR)2025-12-31$48.20M-39.3%
Delcath Systems, Inc. (DCTH)2025-12-31$73.43M+136.8%
Iradimed Corp (IRMD)2025-12-31$64.32M+14.2%
TELA Bio, Inc. (TELA)2025-12-31$54.34M+16.9%

Compare BBNX, NPCE, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗